GO:0070043 rRNA (guanine-N7-)-methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070043 describes the enzymatic activity that transfers a methyl group from S-adenosyl-L-methionine to the N7 position of guanine in ribosomal RNA, producing S-adenosyl-L-homocysteine and N7-methylguanine-containing rRNA.
• This activity is part of the broader RNA cap methylation machinery that coordinates ribosomal RNA production with mRNA cap formation during cell growth.
• The mRNA cap methyltransferase RNMT is upregulated during T cell activation and drives ribosome biogenesis, linking cap methylation to rRNA synthesis.
• c-Myc coordinates mRNA cap methylation and ribosomal RNA production, placing GO:0070043 within a growth-factor-responsive transcriptional program.
• Myc up-regulates formation of the mRNA methyl cap, connecting oncogenic signaling to RNA modification pathways that include rRNA methylation.
• Experimental models for studying GO:0070043 include CRISPR knockout, point-mutation, knock-in, and overexpression cell lines combined with RNA-seq, Ribo-seq, and proteomics.
Description
GO:0070043, rRNA (guanine-N7-)-methyltransferase activity, is a molecular function defined by the catalytic reaction S-adenosyl-L-methionine + rRNA = S-adenosyl-L-homocysteine + rRNA containing N7-methylguanine. This activity introduces a methyl group at the N7 position of guanine within ribosomal RNA, a modification that contributes to the structural and functional maturation of the ribosome. Because ribosome biogenesis is tightly coupled to cell growth and proliferation, enzymes carrying this activity are of interest in cancer biology and developmental studies. The activity is embedded in the broader network of RNA cap methylation, where c-Myc coordinates mRNA cap methylation with ribosomal RNA production to sustain biosynthetic capacity. In T cell activation, upregulation of the RNA cap methyltransferase RNMT drives ribosome biogenesis, illustrating how methylation pathways support rapid cell growth. Myc up-regulation of the mRNA methyl cap further links oncogenic transcription factors to RNA modification enzymes. For researchers, GO:0070043 provides a defined biochemical handle to interrogate how rRNA methylation influences translation, cell proliferation, and disease.
rRNA (guanine-N7-)-methyltransferase activity At A Glance
| GO ID | GO:0070043 |
|---|---|
| GO term | rRNA (guanine-N7-)-methyltransferase activity |
| Ontology | molecular_function |
| Synonym | None listed |
| Definition | Catalysis of the reaction: S-adenosyl-L-methionine + rRNA = S-adenosyl-L-homocysteine + rRNA containing N7-methylguanine |
| Major function | Methylation of guanine at the N7 position in ribosomal RNA |
| Substrate | rRNA and S-adenosyl-L-methionine |
| Product | rRNA containing N7-methylguanine and S-adenosyl-L-homocysteine |
| Related process | Ribosome biogenesis and RNA cap methylation coordination |
What Is GO:0070043?
In plain terms, GO:0070043 is the enzyme activity that puts a methyl group onto the N7 position of guanine in ribosomal RNA. The reaction consumes S-adenosyl-L-methionine as the methyl donor and releases S-adenosyl-L-homocysteine, leaving rRNA with N7-methylguanine. This activity is classified as a molecular_function in the Gene Ontology and is part of the cellular machinery that modifies rRNA during ribosome production.
Why Is rRNA (guanine-N7-)-methyltransferase activity Important in Cell Biology?
GO:0070043 is important because rRNA methylation at guanine N7 is part of the ribosome biogenesis program that supports cell growth and proliferation. The activity is coordinated with mRNA cap methylation by c-Myc, meaning it sits at the interface of transcription, RNA modification, and translation. In activated T cells, upregulation of the cap methyltransferase RNMT drives ribosome biogenesis, showing that methylation enzymes are rate-limiting for biosynthetic expansion. Because Myc up-regulates mRNA methyl cap formation, perturbations in these pathways can influence oncogenic transformation and immune responses. Studying GO:0070043 therefore helps researchers understand how cells tune ribosome output and how this tuning goes awry in disease.
• Provides a biochemical marker for rRNA modification during ribosome biogenesis.
• Links rRNA methylation to mRNA cap methylation through c-Myc coordination.
• Supports T cell activation by driving ribosome biogenesis via RNMT upregulation.
• Connects oncogenic signaling to RNA modification pathways.
• Offers a target for studying translation control in proliferating cells.
• Helps explain how cells allocate S-adenosyl-L-methionine to RNA methylation.
• Relevant to cancer biology because Myc coordinates cap methylation and rRNA production.
• Useful for immunology research on T cell activation and ribosome demand.
• Provides a basis for CRISPR screens targeting RNA modification enzymes.
• Supports development of assays for rRNA methylation status in disease models.
Molecular Mechanism of rRNA (guanine-N7-)-methyltransferase activity
Substrate recognition and binding
In simple terms: The enzyme first grabs the rRNA and the methyl donor.
The activity requires binding of both rRNA and S-adenosyl-L-methionine, the methyl donor. The enzyme must recognize specific structural features of rRNA to position the target guanine for methylation. This step is part of the broader RNA modification machinery that operates during ribosome assembly.
Catalytic methyl transfer
In simple terms: The enzyme moves a methyl group onto the rRNA guanine.
Catalysis proceeds by transfer of the methyl group from S-adenosyl-L-methionine to the N7 position of guanine in rRNA, yielding S-adenosyl-L-homocysteine and N7-methylguanine-containing rRNA. This reaction is classified under GO:0070043 and is a molecular_function in the Gene Ontology. The modification contributes to the maturation and function of ribosomal RNA.
Coordination with mRNA cap methylation
In simple terms: rRNA methylation is timed with mRNA cap methylation.
c-Myc coordinates mRNA cap methylation and ribosomal RNA production, indicating that rRNA methylation activity is integrated with cap methylation pathways. This coordination ensures that ribosome biogenesis matches the demand for protein synthesis during growth. Myc up-regulation of the mRNA methyl cap further supports this integrated program.
Regulation during T cell activation
In simple terms: When T cells wake up, methylation enzymes ramp up ribosome production.
Upregulation of the RNA cap methyltransferase RNMT drives ribosome biogenesis during T cell activation, linking methylation activity to immune cell proliferation. This regulation ensures that activated T cells can meet the increased demand for protein synthesis. The finding places GO:0070043-related methylation within a physiological activation context.
Role of S-adenosyl-L-methionine availability
In simple terms: The methyl donor supply controls how much methylation can happen.
S-adenosyl-L-methionine is the methyl donor for the reaction, so its availability influences the rate of rRNA guanine N7 methylation. Cells must balance SAM consumption across multiple methylation reactions, including mRNA cap methylation and rRNA methylation. This metabolic coupling is part of the coordination described for c-Myc-driven growth programs.
Key Genes Involved in GO:0070043 rRNA (guanine-N7-)-methyltransferase activity
The following genes and proteins are functionally or experimentally linked to rRNA (guanine-N7-)-methyltransferase activity and its coordination with ribosome biogenesis.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYC | Coordinates mRNA cap methylation and ribosomal RNA production | Central to growth-related rRNA methylation studies |
| RNMT | RNA cap methyltransferase upregulated during T cell activation | Drives ribosome biogenesis in activated T cells |
| METTL1 | Methyltransferase implicated in RNA methylation pathways | Candidate for rRNA methylation studies |
| WBSCR22 | Putative rRNA methyltransferase | Model for N7-methylguanine rRNA modification |
| BUD23 | rRNA methyltransferase homolog | Potential target for knockout studies |
| NOP2 | rRNA methyltransferase | Involved in ribosome assembly |
| FTSJ3 | rRNA 2'-O-methyltransferase | Comparative model for rRNA modification |
| DKC1 | rRNA pseudouridine synthase | Ribosomopathy-related rRNA modification |
| NCL | Nucleolin, rRNA processing factor | Interacts with rRNA methylation machinery |
| RPL5 | Ribosomal protein | Ribosome biogenesis readout |
| RPL11 | Ribosomal protein | Ribosome stress marker |
| RPS6 | Ribosomal protein | mTOR pathway readout |
| EIF4E | mRNA cap-binding protein | Links cap methylation to translation |
| POLR1A | rRNA transcription | Upstream of rRNA methylation |
| POLR1B | rRNA transcription | Upstream of rRNA methylation |
| UTP14A | Ribosome assembly factor | Supports rRNA processing |
| RRP1B | Ribosome biogenesis factor | Candidate for CRISPR screening |
How Is rRNA (guanine-N7-)-methyltransferase activity Regulated?
GO:0070043-related activity is regulated in the context of cell growth signaling. c-Myc coordinates mRNA cap methylation and ribosomal RNA production, meaning that growth-promoting transcription factors can influence the demand for rRNA methylation. During T cell activation, RNMT is upregulated and drives ribosome biogenesis, showing that physiological activation signals increase methylation-dependent ribosome output. Myc up-regulation of the mRNA methyl cap further indicates that oncogenic signaling can amplify RNA methylation pathways. Together, these findings suggest that rRNA guanine N7 methylation is not constitutive but is tuned to biosynthetic demand.
rRNA (guanine-N7-)-methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYC | Oncogenic growth and ribosome biogenesis | MYC overexpression cell line |
| RNMT | T cell activation and immune proliferation | RNMT knockout T cells |
| WBSCR22 | Ribosome assembly defects | Point-mutation knock-in |
| NOP2 | Ribosomopathy-like phenotypes | CRISPR knockout |
| DKC1 | Dyskeratosis congenita | Patient-derived iPSC model |
Cancer and oncogenic growth
c-Myc coordinates mRNA cap methylation and ribosomal RNA production, a program that supports the high biosynthetic demand of cancer cells. Because rRNA methylation contributes to ribosome biogenesis, dysregulation of GO:0070043-related enzymes could contribute to oncogenic transformation. Myc up-regulation of the mRNA methyl cap further links RNA modification to cancer biology.
Immune activation and T cell biology
Upregulation of RNMT drives ribosome biogenesis during T cell activation, indicating that methylation pathways are required for immune cell proliferation. Perturbations in this pathway could affect T cell responses and immune homeostasis. This makes GO:0070043-related activity relevant to immunology and immunotherapy research.
Ribosomopathies and translation stress
Defects in rRNA modification and ribosome assembly are linked to ribosomopathies, a group of disorders caused by impaired ribosome biogenesis. Because GO:0070043 contributes to rRNA maturation, its dysfunction could contribute to translation stress. Research on rRNA methylation enzymes helps clarify these disease mechanisms.
From rRNA (guanine-N7-)-methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of rRNA methyltransferase reduce ribosome biogenesis? | CRISPR knockout cell line |
| Does a catalytic point mutation abolish N7-methylguanine formation? | Point-mutation knock-in |
| Can tagged enzyme track rRNA methylation complexes? | Tagged knock-in |
| Does overexpression increase translation output? | Overexpression cell line |
| Which genes buffer rRNA methylation loss? | CRISPR library screening |
| How does Myc coordinate cap and rRNA methylation? | MYC overexpression model |
How to Study the rRNA (guanine-N7-)-methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | rRNA processing intermediates and gene expression | Perturbation studies |
| Ribo-seq | Ribosome occupancy and translation efficiency | Translation profiling |
| Proteomics | Protein abundance and interactions | Complex composition |
| Imaging | Subcellular localization | Nucleolar tracking |
| Methylation mapping | N7-methylguanine in rRNA | Modification detection |
| CRISPR screening | Gene dependencies | Pathway discovery |
| qPCR | rRNA transcript levels | Validation of processing |
RNA sequencing and modification mapping
RNA-seq can profile rRNA processing intermediates and expression changes after perturbation of GO:0070043-related enzymes. Modification mapping approaches can detect N7-methylguanine in rRNA. These methods help link enzyme activity to rRNA maturation.
Ribo-seq and translation profiling
Ribo-seq measures ribosome occupancy and translation efficiency, providing a functional readout of rRNA methylation status. Cells with altered rRNA methylation may show changes in translation output. This method is useful for testing whether GO:0070043 affects protein synthesis.
Proteomics and interactome analysis
Proteomics can identify proteins associated with rRNA methyltransferase complexes and quantify ribosome biogenesis factors. Interactome studies help define the composition of the methylation machinery. These approaches support mechanistic models of GO:0070043 regulation.
Imaging and subcellular localization
Fluorescence imaging can localize tagged rRNA methyltransferases to nucleolar compartments where rRNA processing occurs. Live-cell imaging can track dynamic changes during growth or activation. These methods connect GO:0070043 activity to nucleolar organization.
How CRISPR Can Be Used to Study GO:0070043 rRNA (guanine-N7-)-methyltransferase activity
Knockout
CRISPR knockout of candidate rRNA methyltransferase genes can test whether loss of GO:0070043 activity impairs ribosome biogenesis. Knockout cells can be profiled by RNA-seq and Ribo-seq to measure translation defects. This approach helps establish causality between enzyme activity and cell growth.
Point Mutation
Point-mutation knock-in can disrupt the catalytic site of the methyltransferase while preserving protein expression. Such models distinguish catalytic activity from scaffolding functions. They are useful for testing whether N7-methylguanine formation is required for ribosome function.
Knock-in
Tagged knock-in of the endogenous locus enables tracking of the enzyme and its associated complexes. This approach preserves physiological regulation of GO:0070043 activity. It supports imaging and proteomic studies of rRNA methylation.
Overexpression
Overexpression of rRNA methyltransferases or upstream regulators such as MYC can test whether increased activity drives ribosome biogenesis. Overexpression models are useful for studying oncogenic growth programs. They can be combined with translation profiling to measure functional output.
How EDITGENE Supports rRNA (guanine-N7-)-methyltransferase activity Research
Researchers studying rRNA (guanine-N7-)-methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in rRNA modification, ribosome biogenesis, or cell growth. EDITGENE provides CRISPR-based cell model services that enable precise perturbation of these genes in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for rRNA (guanine-N7-)-methyltransferase activity research.
Frequently Asked Questions About rRNA (guanine-N7-)-methyltransferase activity
What is GO:0070043?
GO:0070043 is the Gene Ontology term for rRNA (guanine-N7-)-methyltransferase activity, the enzyme activity that methylates guanine at the N7 position in ribosomal RNA using S-adenosyl-L-methionine.
What reaction does rRNA (guanine-N7-)-methyltransferase catalyze?
It catalyzes S-adenosyl-L-methionine + rRNA = S-adenosyl-L-homocysteine + rRNA containing N7-methylguanine.
What genes are involved in rRNA (guanine-N7-)-methyltransferase activity?
Genes such as MYC, RNMT, WBSCR22, NOP2, and BUD23 have been linked to rRNA methylation and ribosome biogenesis pathways.
How is rRNA methylation coordinated with mRNA cap methylation?
c-Myc coordinates mRNA cap methylation and ribosomal RNA production, integrating these RNA modification pathways during growth.
Why is rRNA guanine N7 methylation important for T cells?
Upregulation of RNMT drives ribosome biogenesis during T cell activation, supporting the increased protein synthesis demand.
Does Myc regulate rRNA methylation?
Myc up-regulates formation of the mRNA methyl cap and coordinates cap methylation with rRNA production, linking oncogenic signaling to RNA modification.
What diseases are associated with defects in rRNA methylation?
Defects in rRNA modification and ribosome assembly are linked to ribosomopathies and cancer-related growth programs.
How can I study GO:0070043 in the lab?
CRISPR knockout, point-mutation, knock-in, and overexpression models combined with RNA-seq, Ribo-seq, and proteomics are common approaches.
What is the role of S-adenosyl-L-methionine in this activity?
S-adenosyl-L-methionine serves as the methyl donor for the reaction, and its availability influences methylation rate.
Can CRISPR screens identify regulators of rRNA methylation?
Yes, CRISPR library screening can identify genes that modify rRNA methylation pathways and ribosome output.
Conclusion
GO:0070043, rRNA (guanine-N7-)-methyltransferase activity, defines a key enzymatic step in ribosomal RNA modification that supports ribosome biogenesis and cell growth. Its coordination with mRNA cap methylation by c-Myc and its upregulation during T cell activation highlight its importance in proliferation and immune responses. Studying this activity with CRISPR models and functional profiling methods can reveal how rRNA methylation contributes to health and disease.
References
- 1. Dunn S et al.. 2017. c-Myc co-ordinates mRNA cap methylation and ribosomal RNA production.. Biochem J 474(3):377-384 PMID: 27934633
- 2. Galloway A et al.. 2021. Upregulation of RNA cap methyltransferase RNMT drives ribosome biogenesis during T cell activation.. Nucleic Acids Res 49(12):6722-6738 PMID: 34125914
- 3. Cowling VH. 2010. Myc up-regulates formation of the mRNA methyl cap.. Biochem Soc Trans 38(6):1598-601 PMID: 21118133
